Full-Time
Executive Director/ Sr. Director of Medical Affairs
Confirmed live in the last 24 hours
Develops off-the-shelf genetically modified T cells
Compensation Overview
$297,000 - $409,000Annually
Senior, Expert
San Carlos, CA, USA
- MD, PhD, or PharmD. MD/PhD a plus.
- Broad and deep knowledge of Autoimmune disease and the hematology-oncology landscape.
- Prior experience working on early-stage and mid-stage oncology programs.
- Fluency with translational data-rich development programs and ability to engage the medical and scientific community.
- Setting up and overseeing effective interactions with key opinion leaders, patient advocacy groups, and medical institutions in areas of hematology-oncology and autoimmune diseases.
- Organizing and conducting advisory boards, reaching out to patient advocacy groups, and playing a key role in establishing and maintaining a vibrant network of global experts supporting the development of Adicet’s pipeline.
- Being the main point of contact for Investigator Sponsored Trials involving Adicet’s programs.
- Co-authoring and reviewing company-sponsored trial protocols in collaboration with clinical development.
- Coordinating medical communication activities internally and externally.
Adicet Bio, Inc is at the forefront of developing off-the-shelf genetically modified gamma delta T cells that specifically target tumors. By employing cutting-edge techniques like chimeric antigen receptors and T cell receptor-like antibodies, this biotechnology company is leading the way in enhancing selective tumor targeting and improving treatment persistence for long-lasting effects in patients. Working here offers an opportunity to be part of a pioneering team dedicated to groundbreaking biological research in cancer treatment, positively impacting patient outcomes in a supportive and innovative environment.
Company Stage
IPO
Total Funding
$243.6M
Headquarters
Redwood City, California
Founded
2014